Want to see IN:APOLLOHOSP full AI Analyst Report?
APOLLOHOSP Stock Chart & Stats
₹8878.00
₹38.00(0.43%)
At close: 4:00 PM EDT
₹8878.00
₹38.00(0.43%)
Day’s Range― - ―
52-Week Range₹6,680.00 - ₹9,326.80
Previous CloseN/A
Volume135.16K
Average Volume (3M)42.04K
Market Cap
₹1.12T
Enterprise Value₹1.14T
Total Cash (Recent Filing)₹18.56B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)54.2
Beta0.87
Next Earnings
Nov 04, 2026EPS Estimate
43.36Next Dividend Ex-DateN/A
Dividend Yield0.25%
Share Statistics
EPS (TTM)145.34
Shares Outstanding143,784,650
10 Day Avg. Volume90,129
30 Day Avg. Volume42,038
Financial Highlights & Ratios
PEG Ratio1.60
Price to Book (P/B)11.25
Price to Sales (P/S)4.23
P/FCF Ratio149.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹10,260.00Price Target Upside15.57% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)171.74
Revenue Forecast (FY)₹300.46B
Bulls Say, Bears Say
Bulls Say
Revenue GrowthThe sharp improvement in revenue growth indicates stronger demand and operating momentum across Apollo’s healthcare network. If sustained, higher patient volumes and service activity can support scale benefits, reinforce market position, and provide a durable base for further earnings expansion.
Profitability ImprovementExpanding net and operating margins show that recent growth is translating into better profitability rather than merely adding low-return revenue. Sustained operating improvement would strengthen internal funding capacity, improve resilience, and support reinvestment across hospitals and related services.
Strong ReturnsThe rising return on equity demonstrates improving efficiency in converting shareholder capital into earnings. This strengthens the quality of Apollo’s growth, suggests better utilization of its healthcare assets, and can support long-term compounding if returns remain above historical levels.
Bears Say
Rising LeverageDebt approaching the level of equity reduces financial flexibility and makes the business more dependent on sustained utilization and pricing. Higher leverage can also increase financing obligations, constrain future expansion choices, and amplify the impact of any operational slowdown.
Weak Cash ConversionLow and declining free-cash-flow conversion means accounting earnings are not consistently translating into discretionary cash. Heavier reinvestment, capital expenditure, or working-capital needs may limit internally funded growth, while recent cash-flow volatility reduces financial predictability.
Margin PressureThe decline in gross margin indicates that underlying cost or service-mix pressures remain despite stronger operating and net margins. Continued volatility could limit the durability of earnings improvement and make future profitability more sensitive to patient mix, pricing, and operating execution.
Apollo Hospitals Enterprise Limited News
APOLLOHOSP FAQ
What was Apollo Hospitals Enterprise Limited’s price range in the past 12 months?
Apollo Hospitals Enterprise Limited lowest stock price was ₹6680.00 and its highest was ₹9326.80 in the past 12 months.
What is Apollo Hospitals Enterprise Limited’s market cap?
Apollo Hospitals Enterprise Limited’s market cap is ₹1.12T.
When is Apollo Hospitals Enterprise Limited’s upcoming earnings report date?
Apollo Hospitals Enterprise Limited’s upcoming earnings report date is Nov 04, 2026 which is in 21 days.
How were Apollo Hospitals Enterprise Limited’s earnings last quarter?
Apollo Hospitals Enterprise Limited released its earnings results on Aug 12, 2026. The company reported ₹40.4 earnings per share for the quarter, beating the consensus estimate of ₹38.93 by ₹1.47.
Is Apollo Hospitals Enterprise Limited overvalued?
According to Wall Street analysts Apollo Hospitals Enterprise Limited’s price is currently Undervalued.
Does Apollo Hospitals Enterprise Limited pay dividends?
Apollo Hospitals Enterprise Limited pays a Semiannually dividend of ₹10 which represents an annual dividend yield of 0.25%. See more information on Apollo Hospitals Enterprise Limited dividends here
What is Apollo Hospitals Enterprise Limited’s EPS estimate?
Apollo Hospitals Enterprise Limited’s EPS estimate is 43.36.
How many shares outstanding does Apollo Hospitals Enterprise Limited have?
Apollo Hospitals Enterprise Limited has 143,784,650 shares outstanding.
What happened to Apollo Hospitals Enterprise Limited’s price movement after its last earnings report?
Apollo Hospitals Enterprise Limited reported an EPS of ₹40.4 in its last earnings report, beating expectations of ₹38.93. Following the earnings report the stock price went down -2.125%.
Which hedge fund is a major shareholder of Apollo Hospitals Enterprise Limited?
Currently, no hedge funds are holding shares in IN:APOLLOHOSP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited, through its group entities, delivers a comprehensive range of medical services both within India and across international borders. Its medical infrastructure spans primary, secondary, and tertiary levels of care. Within its tertiary hospitals, advanced medical treatments are available, specializing in fields such as cardiology, cancer treatment (oncology), neurology, orthopedics, urgent care, robotic surgical procedures, and organ transplantation. Beyond direct patient care, the company extends its offerings to include project advisory services, health coverage solutions, the operation of medical educational institutions, an e-learning platform called Medvarsity, and research initiatives. Furthermore, its operations encompass retail pharmacies, foundational primary care clinics, maternity and specialized birthing centers, focused single-specialty clinics, general primary health centers, diagnostic lab networks, dental clinics, as well as daycare and in-home healthcare services. The company's extensive presence is marked by 9,911 hospital beds, 4,529 pharmacies, and 1,734 retail healthcare centers nationwide. This is complemented by its digital ventures: Apollo 24/7, a comprehensive omni-channel healthcare platform, and www.apollopharmacy, its online pharmaceutical retail outlet. Established in 1979, Apollo Hospitals Enterprise Limited maintains its corporate headquarters in Chennai, India.
APOLLOHOSP Stock 12 Month Forecast
Average Price Target
₹10,260.00
▲(15.57% Upside)
Technical Analysis
Aster DM Healthcare Ltd.
―
Fortis Healthcare Ltd.
―
Max Healthcare Institute Ltd
―
Global Health Limited
―
Narayana Hrudayalaya Ltd.
―



